With the vaccine production market registering increased growth rates across the pharmaceutical and biotechnology industries, it is critical to partner with a company that has expertise across the development process to get the safest and most effective vaccines to market. Charles River has consistently and effectively supported the vaccine development industry for decades with its unique range of products and related services. Working with our global network of scientific, technical and regulatory experts provides vaccine developers with the right expertise early in the vaccine development process to boost productivity, efficiency and profitability.
We are pleased to announce that we have recently expanded our Ballina, Ireland facility to offering more capacity and improved timelines for challenge studies and effective vaccine development. Click here to learn more and to view a video about the new facility.
Visit our Regulatory Document Library to access regulatory documents on vaccines from the FDA, EMA, MHLW, WHO and more.
Capabilities to Support Development and Commercialization of Vaccines
Related Vaccine Study Information
For a copy of our Preclinical Vaccine Researcher newsletter and access to our archived vaccine webinars, please log in to the Source℠.
If you are not a member of the Source℠, our new online scientific and educational information center, click here to register.
For more information on our capabilities that help support the development and commercialization of vaccines, contact us at 1.877.CRIVER.1 or firstname.lastname@example.org.